Autosomal dominant mutations in the gene encoding the basic helix-loop-helix transcription factor Twist1 are associated with limb and craniofacial defects in humans with Saethre-Chotzen syndrome. The molecular mechanism underlying these phenotypes is poorly understood. We show that ectopic expression of the related basic helix-loop-helix factor Hand2 phenocopies Twist1 loss of function in the limb and that the two factors have a gene dosage-dependent antagonistic interaction. Dimerization partner choice by Twist1 and Hand2 can be modulated by protein kinase A-and protein phosphatase 2A-regulated phosphorylation of conserved helix I residues. Notably, multiple Twist1 mutations associated with Saethre-Chotzen syndrome alter protein kinase A-mediated phosphorylation of Twist1, suggesting that misregulation of Twist1 dimerization through either stoichiometric or post-translational mechanisms underlies phenotypes of individuals with Saethre-Chotzen syndrome.
Autosomal dominant mutations in the gene encoding the basic helix-loop-helix transcription factor Twist1 are associated with limb and craniofacial defects in humans with Saethre-Chotzen syndrome. The molecular mechanism underlying these phenotypes is poorly understood. We show that ectopic expression of the related basic helix-loop-helix factor Hand2 phenocopies Twist1 loss of function in the limb and that the two factors have a gene dosage-dependent antagonistic interaction. Dimerization partner choice by Twist1 and Hand2 can be modulated by protein kinase A-and protein phosphatase 2A-regulated phosphorylation of conserved helix I residues. Notably, multiple Twist1 mutations associated with Saethre-Chotzen syndrome alter protein kinase A-mediated phosphorylation of Twist1, suggesting that misregulation of Twist1 dimerization through either stoichiometric or post-translational mechanisms underlies phenotypes of individuals with Saethre-Chotzen syndrome.
Studies of developing vertebrate limbs have yielded many insights into the process of embryonic pattern formation. Prominent among these is the identification of a growing catalog of transcription factors that orchestrate limb patterning. The genetic and biochemical interactions of these transcription factors are important for integrating patterning information but are poorly understood. Twist1 and Hand2 are basic helix-loop-helix (bHLH) transcription factors in the Twist family that may be useful for investigating such interactions. Each is required for distinct yet subtly related aspects of limb development, and biochemical studies uncovered a complex regulation of their protein-protein interactions [1] [2] [3] .
Early limb bud expression of Twist1 is observed primarily in the peripheral mesenchyme, and Twist1 is required for maintenance of the overlying apical ectodermal ridge (AER) [4] [5] [6] [7] . Twist1 haploinsufficiency in mice and humans is associated with a range of limb abnormalities. Twist1 +/À heterozygous null mice have a partially penetrant preaxial polydactyly 8, 9 . Human TWIST1 nonsense, missense and null alleles 8, [10] [11] [12] are associated with distal limb abnormalities (including polydactyly, brachydactyly and syndactyly), as seen in individuals with the autosomal dominant craniosynostosis disorder Saethre-Chotzen syndrome (SCS) 12 . Some TWIST1 missense alleles have deficient nuclear localization or impaired DNA binding in vitro 13, 14 , but the mechanism by which many TWIST1 mutations cause SCS is not known.
After the onset of limb bud outgrowth, Hand2 is expressed primarily in the posterior limb mesenchyme, where it is both dependent on and necessary for normal sonic hedgehog (Shh) expression [15] [16] [17] . Furthermore, ectopically expressed Hand2 in the anterior limb mesenchyme induces preaxial polydactyly and activates the Shh pathway, although it does not always induce ectopic expression of Shh [15] [16] [17] . Hand2 seems to act through a maintenance loop with Shh, but additional functions for Hand2 are possible, as the Hand2 expression domain is broader than that of Shh [15] [16] [17] . Both Twist1 and Hand2 are associated with polydactylous limb phenotypes, suggesting that they may interact genetically or biochemically.
Although numerous genetic and functional studies of Twist-related bHLH factors have been reported 1, 3, 18 , direct interactions between Twist1 and Hand2 have not been described. A number of Twist family proteins, including Twist1 and Hand2, dimerize not only with ubiquitously expressed E proteins but also with other class B bHLH proteins and can form stable homodimers [19] [20] [21] . Furthermore, the choice of dimerization partners by a related Twist family member, Hand1, can be modulated by the phosphorylation state of specific conserved residues in helix I (ref. 20) . Thus, Twist1-Hand2 interactions might depend on partner availability as well as regulatory post-translational modifications that influence protein-protein interactions 18 .
Here we investigate the biochemical and genetic interactions between Twist1 and Hand2 both in vitro and during limb development. We show that protein kinase A (PKA) and B56d-containing protein phosphatase 2A (PP2A) can regulate phosphorylation of Twist1 and Hand2 at the conserved helix I residues, that hypophosphorylation and phosphorylation mimics of these residues alter bHLH dimerization affinities and that this phosphoregulatory circuit is dysregulated in a group of TWIST1 mutations that cause SCS in humans. We also show that ectopic Hand2 expression phenocopies SCS in limb, that the appropriate genetic dosage of Hand2 and Twist1 is crucial for proper limb development and that these interactions require the phosphoregulated helix I residues. These findings suggest that choice of dimerization partners in the Twist family is modulated by both the relative levels of gene expression and the phosphorylation state of key helix I residues, thereby dictating changes in the regulation of their downstream target genes. We propose that the disruption of this regulatory mechanism in a subset of TWIST1 mutations underlies the phenotypes observed in SCS.
RESULTS

PKA and PP2A regulate Twist1 and Hand2 phosphorylation
Sequence comparisons indicate that the phosphorylation-regulated threonine and serine residues in helix I of Hand1 are highly conserved among the bHLH domains of Twist family proteins and are conserved among Twist1 homologs as distant as Drosophila Twist (Fig. 1a) . By contrast, threonine and serine residues at this position in helix I are not generally found in bHLH proteins outside of the Twist family. This conservation raised the possibility that modulating the phosphorylation state of these residues might control the activity of not only Hand1 (ref. 20) but also Twist1, Hand2 and other Twist-related factors.
To test whether the conserved helix I residues of Twist1 and Hand2 could be phosphorylated by PKA, we coexpressed wild-type Hand2 and Twist1 or the double alanine substitution mutants Hand2 T112A S114A and Twist1 T125A S127A with constitutively active PKA in metabolically labeled HEK293 cells (Fig. 1b) . Immunoprecipitation of radiolabeled proteins showed that PKA could phosphorylate Hand2 and Twist1; moreover, specific mutation of the conserved helix I residues reduced the amount of 32 P incorporated into either Hand2 or Twist1 (Fig. 1b) .
We next asked whether Twist1 and the PP2A regulatory subunit B56d could form a complex by coexpressing Twist1 with either B56d or the related PP2A subunit B56a in HEK293 cells (Fig. 1c) . Immunoprecipitation followed by immunoblot analysis showed that Flagtagged Twist1 coimmunoprecipitated substantial amounts of B56d but relatively small amounts of B56a (Fig. 1c) . Twist1 seems to have a stronger interaction with B56d than with Hand1 (Fig. 1b) . Thus, as reported for Hand proteins 20 , Twist1 can be phosphorylated by PKA and interacts specifically with the PP2A regulatory subunit B56d.
We next sought to determine whether the conserved helix I threonine and serine residues are PKA phosphorylation targets and whether B56d facilitates specific dephosphorylation of Twist1 and Hand2. We carried out phosphopeptide mapping analyses of wild-type and hypophosphorylation mutants of these proteins coexpressed with active PKA and B56d or B56a in metabolically labeled HEK293 cells (Fig. 2) . PKA coexpression resulted in two new Hand2 phosphopeptides and increased phosphorylation of an additional phosphopeptide (Fig. 2a,b) . Addition of B56a reduced 32 P incorporation in a single peptide (compared with coexpression of Hand2 and PKA; Fig. 2c,l) . This suggests that B56a can moderately affect Hand2 phosphorylation, although evidence for direct protein-protein interaction is lacking. Coexpression of Hand2, PKA and B56d further reduced phosphorylation of this peptide (phosphorylation was 38% of that observed with coexpression of Hand2 and PKA; Fig. 2d,l) . Moreover, mutation of the conserved residues Thr112 and Ser114 to alanines reduced 32 P incorporation into this peptide to undetectable levels (Fig. 2e,l) .
To define further which residues of Hand2 are phosphorylated, we raised polyclonal antisera against a Hand protein helix I peptide that contains a phosphorylated serine at position 114 and used it to immunoblot extracts of HEK293 cells transfected with various Hand2 mutants in combination with PKA (Fig. 2m) . This antiserum detects wild-type Hand2 only when it is coexpressed with PKA (Fig. 2m) . The T112A S114A mutation reduced this phosphospecific band to undetectable levels, whereas the basic domain T103A mutation had no effect. These data provide additional evidence that Ser114 of Hand2 is phosphorylated by coexpression of Hand2 with constitutive PKA. Coexpression of Twist1 and active PKA also resulted in increased protein phosphorylation (Figs. 1b and 2f,g ). The addition of B56a had a negligible effect on Twist1 phosphorylation (phosphorylation was 94% of that observed with wild-type Twist1; Fig. 2h,l) . In contrast, coexpression of Twist1, PKA and B56d reduced the phosphorylation of a single Twist1 phosphopeptide by 75% (Fig. 2i,l) , and mutation of Thr125 and Ser127 to alanines reduced this phosphorylation to undetectable levels (Fig. 2j) . Thus, Hand2 and Twist1 can be post-translationally modified by PKA and B56d, consistent with the idea that a regulatory circuit uses the helix I phosphorylation state to control the activity of these proteins.
Twist1 SCS mutations alter Thr125 and Ser127 phosphorylation Missense mutations of several basic domain residues in human TWIST1 are associated with SCS 8, [10] [11] [12] 22, 23 . Because the mutated residues are adjacent to the phosphorylated helix I residues, these mutations might disrupt the Twist1 PKA-PP2A regulatory circuit. We therefore assessed the phosphorylation of Twist1 mutated at each basic domain residue (Arg118, Arg120, Gln121 and Arg122) individually ( Fig. 3a-h ). Each mutation greatly reduced the phosphorylation of Thr125 and Ser127 by PKA in metabolically labeled HEK293 cells (Fig. 3) .
Three of these mutations replace positively charged residues, suggesting that the degree of PKA-mediated phosphorylation is proportional to the basic character of the basic domain. By contrast, a dominant negative Caenorhabditis elegans Twist E29K mutation 24 increases the alkalinity of the basic domain and, therefore, might enhance PKA-mediated phosphorylation. Phosphopeptide mapping analysis of the analogous Twist1 E117K mutant showed increased phosphorylation, confirming that PKA-mediated phosphorylation was proportional to the basic character of the basic domain (Fig. 3i,j) . Taken together, these data show that Twist1 helix I phosphorylation can be modified by mutation of nearby residues, including residues that are mutated in individuals with SCS.
Twist1-Hand2 dimerization is regulated at Thr125 and Ser127
We next tested how differential phosphorylation might affect the activities of Hand2 and Twist1. Hand1 and Hand2 can form homoor heterodimers, and choice of dimerization partner by Hand1 can be phosphoregulated 19, 20 . Interactions between Twist1 and other Twist family members might be similarly regulated. We therefore asked whether Twist1 can heterodimerize with Hand1 or Hand2 and whether mimicking phosphorylation at the conserved threonine and serine residues can regulate Twist1 dimerization affinities.
To assess the ability of Twist1 to complex with Hand proteins, we carried out immunoprecipitation-immunoblot analysis on extracts of HEK293 cells cotransfected with epitope-tagged forms of Twist1, Hand1 and Hand2 (Fig. 4a) . Expression of Flag-tagged Twist1 with Myc-tagged Hand1 or Hand2 resulted in specific coimmunoprecipitation of Twist1 with either Hand protein. As expected, Hand protein heterodimeric and homodimeric complexes were also readily detectable when epitope-tagged Hand1 or Hand2 was coexpressed.
Fluorescence resonance energy transfer (FRET) occurs between donor and acceptor fluorescent molecules when they are in close To compare interactions between various Twist1 dimerization partners, we used acceptor photobleaching FRET to measure the fraction of donor fluorescence that is absorbed by the acceptor (FRET efficiency) 25 . We generated both cyan fluorescent protein (CFP) and yellow fluorescent protein (YFP) C-terminal fusions of E47, Hand2 and wild-type and Thr125 Ser127 mutant Twist1, coexpressed them in HEK293 cells and measured FRET efficiencies (Fig. 4b) . Wildtype Twist1 formed dimers with itself, with E47 and, most strongly, with Hand2. The Twist1 phosphorylation mimic T125D S127D dimerized less, affecting E47-Twist1 heterodimers and Twist1 homodimers to a greater extent than Hand2-Twist1 heterodimers. Reduced FRET efficiency was also observed in the hypophosphorylation mutant T125A S127A, with Hand2-Twist1 heterodimers affected more severely than E47-Twist1 heterodimers. By contrast, Twist1 T125A S127A homodimers showed higher FRET efficiency than wild-type Twist1 homodimers. This results in distinctly different relative FRET efficiencies for Twist1 T125A S127A versus either wild-type Twist1 or Twist1 T125D S127D. Taken together, these findings suggest that alteration of the phosphorylation state of Twist1 at Thr125 and Ser127 affects the dimerization affinity of Twist1 for its various potential partners, including Hand2.
Twist1 and Hand2 expression domains in limb bud overlap Having established that Twist1 and Hand2 can interact in vitro, we next sought to determine whether they interact in vivo during embryonic development. We chose to examine the developing vertebrate limb bud, because previous studies indicated that both genes are expressed in the limb 6, 7, [15] [16] [17] . Twist1 and Hand2 expression domains overlapped in both chick and mouse limb mesenchyme throughout limb (Fig. 5) . Twist1 is expressed broadly in the peripheral mesenchyme from Hamburger-Hamilton stages 19-30 (ref. 26) in chick and from embryonic day (E) 9.5-E12.5 in mouse, with elevated levels observed at the anterior and posterior margins. Hand2 expression is initially restricted to the posterior mesenchyme and expands progressively towards the distal anterior. There is also a minor anterior proximal Hand2 expression domain. Twist1 and Hand2 were initially coexpressed in the posterior limb mesenchyme, and the region of overlap expanded by stage 24 or E11.5 to include much of the distal mesenchyme underlying the AER (Fig. 5a-h,q-t) . At the time of digital condensation, extensive interdigital expression of both genes was observed (Fig. 5i-l) . Overlapping expression was later observed in the peridigital mesenchyme at stage 30 or E12.5 ( Fig. 5m-p) . These results indicate that Twist1 and Hand2 are coexpressed in distinct regions of the developing vertebrate limb, consistent with the idea that these two factors may functionally interact.
Hand2 misexpression phenocopies Twist1 loss of function If Hand2 and Twist1 act together in the limb, then misexpression of Hand2 might cause phenotypes related to those caused by mutations in Twist1. To test this possibility, we used a replication-competent retrovirus to misexpress wild-type Hand2 in developing chick limbs by general or focal infection at stages 10-20 and examined cartilage, soft tissue and molecular phenotypes through E10 (Fig. 6) . We observed preaxial polydactyly in wings stained for cartilage patterning. Affected anterior digit identities varied widely, ranging from cartilage blebs and posterior transformations through induction of ectopic digit 3s (Fig. 6a-c) . These observations are consistent with previous reports, but the extent of the digit duplications was more severe than previously described following Hand2 misexpression in chick limbs 15, 16 . We also observed several new limb phenotypes distinct from those previously associated with Hand2 misexpression. These include frequent cases of syndactyly (Fig. 6d,e) , shortened cartilage elements in digits and long bones (Fig. 6f,g ) and occasional bent digits (Fig. 6h,i) . We also detected AER disruptions, as indicated by gaps in the expression of the AER marker Fgf8 (Fig. 6j,k) , and regions of reduced distal mesenchyme outgrowth (Fig. 6l,m) , consistent with disrupted AER maintenance. This combination of limb phenotypes caused by ectopic Hand2 expression resembles those seen in Twist1 +/À mice or humans with reduced or altered TWIST1 activity (syndactyly, brachydactyly, hallux valgus, AER disruption and polydactyly) 4, 12 . This similarity is consistent with the idea that Twist1 and Hand2 have antagonistic functions in limb development.
Genetic interactions between Twist1 and Hand2
We next examined genetic interactions between Twist1 and Hand2 to test for functional antagonism. If these genes interact antagonistically, then either reducing Hand2 levels to compensate for reduced expression of Twist1 or increasing Twist1 levels when misexpressing Hand2 might change their respective effects on limb development. We first asked whether lowering Hand2 levels would suppress the effects of reduced Twist1. Hand2 heterozygous null mice were normal, but Twist1 heterozygous null mice had a partially penetrant preaxial polydactyly of the hindlimbs 8,9 (Fig. 7a) . We intercrossed Twist1 +/À and Hand2 +/À mice to determine whether lowering Hand2 gene dosage would rescue the Twist1 +/À -mediated polydactyly (Fig. 7b) .
We found that 18 of 43 (42%) F 1 Twist1 +/À mice had hindlimb polydactyly, whereas their F 1 Hand2 +/À siblings were all normal (53 of 53). We never observed polydactyly in F 1 compound Hand2 +/À Twist1 +/À offspring (0 of 44; P oo 0.01, w 2 ). These results suggest that there is a dose-dependent requirement for Hand2 and show that the relative levels of Hand2 and Twist1 critically affect limb development. We then tested whether increased Twist1 expression could compensate for increased Hand2 levels by misexpressing Hand2 in combination with either Twist1 or GFP as a control. We coinfected the anterior of wing buds of stage 20 chicks with two viruses that allow simultaneous transduction of two genes. We noted the identities of ectopic digits at E10, scored each limb based on the digit with the most posterior identity and compared the frequency distribution for each virus combination (Fig. 7c) . As the degree of digit posteriorization is proportional to the strength of polarizing signal or Shh pathway activation 27, 28 , we could quantify the activity of the virally expressed proteins. Infection with Hand2 plus GFP induced a range of duplications, with an ectopic digit 3 noted in 64% of limbs, digit 2 in 21% and no ectopic digit in 15%. The extent of duplications induced by infection with Hand2 plus Twist1 was significantly weaker, with an ectopic digit 3 in only 38% of limbs, digit 2 in 28% and no ectopic digit in 35% (P oo 0.01, Mann-Whitney). Infection with focal anterior Twist1 virus alone had no effect on limb morphology, although Twist1 did cause gross cartilage abnormalities when misexpressed throughout the limb bud, providing independent confirmation of Twist1 virus activity (Fig. 7c and data not shown) . Therefore, increasing Twist1 levels can suppress the effects of increased Hand2. We also tested whether the conserved helix I threonine and serine residues are required for the ability of Twist1 to suppress the Hand2 misexpression phenotype. We generated a retrovirus carrying the Twist1 helix I double alanine substitution and tested it in the anterior limb coinfection assay. As observed with wild-type Twist1, anterior misexpression of mutated Twist1 alone did not cause patterning defects. Unlike the wild-type gene, however, mutated Twist1 had no effect on the ability of Hand2 to cause digit duplications (Hand2 plus GFP, 69% ectopic digit 3; Hand2 plus mutated Twist1, 69% ectopic digit 3; Fig. 7d) . Thus, the same helix I mutation that prevents Twist1 phosphorylation and alters Twist1 dimerization partner preference also disrupts Twist1 biological activity in vivo.
DISCUSSION
In this study, we describe two mechanisms by which the activities of Twist1 and Hand2 can be regulated: (i) changes in their relative levels of expression and (ii) phosphorylation. Specific threonine and serine residues in helix I shared by Twist1 and Hand2 are conserved in most Twist family members. These residues can be post-translationally modified by PKA and B56d-containing PP2A, and dimerization affinity can be altered by such modifications. We also found that ectopic Hand2 expression phenocopies limb phenotypes resulting from mutations in Twist1, including those found in individuals with SCS. Furthermore, we show that there is a gene dose-dependent interaction between Twist1 and Hand2 in both combination gain-offunction and combination loss-of-function experiments and show that a mutation that alters Twist1 dimerization and phosphorylation in vitro also alters its genetic interactions with Hand2 in vivo. These data strongly support models in which Twist family bHLH protein dimerization partner choice is crucial for normal development.
Early models of bHLH function posited that competition between transcriptionally active E proteins and transcriptionally inactive HLH proteins for dimerization with tissue-specific bHLH proteins was the primary mechanism regulating the formation of bHLH complexes 18, 29 . We now know that regulation by both phosphorylation and interactions with a wider spectrum of dimerization partners is a concept that should be added to this model. We previously showed that PKA and B56d-containing PP2A regulate Hand1 dimerization affinities for other bHLH proteins through phosphorylation of helix I (ref. 20) . Our current finding that Twist1 and Hand2 are similarly modified suggests that other Twist family proteins that share the phosphorylated helix I residues may also share this regulatory polydactyly by coexpression of chick Twist1 but not a chick Twist1 T109A S111A mutant (mut). Anterior right wing buds were infected at stage 20 with chick Hand2 plus GFP viruses, chick Hand2 plus chick Twist1 or chick Twist1 virus alone, and skeletal preparations were scored at E10 for the ectopic anterior digit with the most posterior identity. Limbs with ambiguous ectopic digit identities (an equally small fraction of cases for each experiment) were excluded from the analysis. (c) Twist1 (n ¼ 156) significantly shifts the chick Hand2 plus GFP (n ¼ 124) distribution to less severe phenotypes (P oo 0.01, Mann-Whitney). (d) Chick Twist1 T109A S111A (n ¼ 84) has no effect on the distribution of phenotypes induced by chick Hand2 plus GFP (n ¼ 81, P 4 0.5, Mann-Whitney). Neither chick Twist1 (n ¼ 21) nor chick Twist1 T109A S111A (n ¼ 13) infection alone caused polydactyly (c,d).
mechanism. The embryological importance of the Twist1 post-translational modifications is reflected in the phenotypes observed in individuals with SCS 12 , in C. elegans models and in the data presented here (Fig. 7) in which Twist1 point mutations that disrupt the PKA-PP2A circuit alter the developmental activity of Twist1 (ref. 24) . These observations provide a potential mechanistic explanation for several mutations found in individuals with SCS. These include five basic domain mutations and a mutation of the conserved phosphorylationregulated helix I serine 10, 12, 24 . The use of phosphorylation to regulate Twist family dimerization may extend beyond interactions with the Twist family and E proteins. For example, Twist1 can bind the myogenic factor MyoD and negatively regulate its activity 30, 31 . The Twist1 triple mutation R120A R122A R124A was reported to disrupt interactions between MyoD and Twist1 (ref. 30 ). Our results show that mutating these residues individually also disrupts PKA-mediated phosphorylation of Twist1 helix I (Fig. 3) . These data are consistent with the idea that the MyoD and Twist1 interaction may be regulated in part by phosphorylation of Twist1.
Although the Twist1 basic domain mutations can affect the ability of PKA to phosphorylate the helix I residues, the developmental effects may result solely from changes in DNA binding specificity. We feel this is unlikely for several reasons. First, C. elegans Twist carrying several of the SCS mutations tested here remains capable of DNA binding as Twist-Daughterless heterodimers 24 . Nevertheless, DNA binding is not required for all Twist1 activity, as a Twist1 mutant with a non-DNA binding basic domain can still inhibit transcriptional activation by MyoD and Mef2 (ref. 31) . Similarly, Hand2 that lacks the basic domain remains competent to induce polydactyly when misexpressed in mouse limbs 32 . Thus, multiple lines of evidence indicate that Twist1 has DNA binding-independent activities that may be influenced by properties of its basic domain.
Proper Twist1 gene dosage is known to be crucial for normal development, but the molecular basis for this requirement is not well understood 8, 9, 11, 12 . Our results indicate that at least in the limb, reduced Twist1 or increased Hand2 dosage disrupts an antagonistic balance between Twist1 and Hand2. Hand2 and Twist1 are expressed in the limb in overlapping domains, and these proteins can form heterodimers with each other, homodimers or heterodimers with other partners. Changing the Twist1:Hand2 dosage probably alters the relative amounts of the various possible protein combinations, leading to changes in target gene expression and consequent developmental defects. Although we do not know which complexes are most important, specific Twist dimer complexes may differentially regulate transcription of target genes 21 , and so each unique dimer probably has unique biological activities. Studies in Drosophila using forced dimers show that Twist homodimers specify mesoderm and the somatic myogenic lineage, whereas Twist-Daughterless heterodimers repress the transcription of genes required for somatic myogenesis 21 . A similar experimental strategy may help define the functions of the various Twist1 and Hand2 dimer combinations in the limb.
Some of the ectopic Hand2 limb phenotypes reported here may reflect a normal developmental mechanism in which high levels of Hand2 are required to antagonize Twist1 activity. The AER disruption associated with Hand2 misexpression is one example. AER disruption can be observed adjacent to ectopic outgrowths that correspond to sites of Hand2 virus infection and is, therefore, presumed to be due to high levels of Hand2 expression (Fig. 6 and data not shown) . Because Twist1 is normally required in the mesenchyme for the function of an FGF signaling loop between mesenchyme and ectoderm that maintains the AER 4,5,33 , the Hand2 virus phenotype may be caused by interference with this Twist1 activity. Hand2 expression is normally highest in the posterior limb, adjacent to ectoderm just proximal of the AER and from which the AER has regressed in concert with distal limb outgrowth. Thus, one normal function of high-level Hand2 expression may be to limit the posterior-proximal extent of the AER.
A recently described C-terminal 'Twist domain' conserved in Twist1 and Twist2 binds Runx proteins and inhibits Runx transcriptional activity 34 . As Runx2 promotes ossification of cartilaginous and membranous bone, Twist proteins delay the onset of ossification. In individuals with SCS, either mutating the Runx-binding domain or reducing Twist1 levels has been proposed to generate excess free Runx2 protein that promotes premature ossification, resulting in craniofacial and skeletal defects. How Hand2 activity fits into this paradigm is not known. Hand2 levels in the limb may modulate the availability of Twist1 for interaction with Runx proteins. Or, as polydactyly has not been reported for mutations in Runx genes [35] [36] [37] [38] , interactions between Hand2 and Twist1 in the early limb may operate independently of Runx pathways. Whether changes in Hand2 gene dosage can alter osteogenic SCS phenotypes is a good question. Similarly, the Twist1 double alanine mutation tested here does not suppress the Hand2-induced polydactyly phenotype and also does not cause gross cartilage defects. Whether the loss of this latter activity is due to defective Hand2 interactions or reflects a requirement for these residues for broader aspects of Twist1 functionality remains to be determined. These and future studies will expand our understanding of how combinatorial interactions among broadly expressed transcription factors drive highly context-specific developmental programs.
METHODS
Constructs.
We constructed Twist1 and Hand2 retroviruses by subcloning wildtype chick Twist1, chick Twist1 carrying the T109A S111A mutation or Hand2 cDNAs into the RCAS BP(A) and RCAS BP(B) vectors 39 . The chick Twist1 constructs contain an N-terminal Flag epitope tag (Sigma). RCAS BP(A) GFP was described previously 39 . pIRES Flag-Hand1 and Hand2 encode N-terminal Flag epitope tag fusions cloned into pIRES NEO (Clontech). B56a and B56d cDNAs were cloned into the expression vector pCEP4-l. Full length E12 and E47 were a gift from Y. Kee and M. Bronner-Fraser (California Institute of Technology). Myc-and Flag-tagged mouse Twist1 were a gift from E. Olson (UT Southwestern medical center). E-protein and Hand YFP and CFP fusion proteins were made as described 20 . Twist1 YFP and CFP fusion proteins were cloned by inserting the Twist1 cDNA beginning from codon 3 in frame into pEYFP-N1 and pECFP-N1 (Clontech). Hand2 and Twist1 point mutants were generated using the QuikChange Mutagenesis kit (Stratagene) in accordance with the manufacturer's protocols.
Cell culture, metabolic labeling and immunoprecipitations. We grew HEK293 cells and transfected them as described 20 with the indicated constructs. In some experiments, we split a single CaPO 4 precipitate onto duplicate plates and used one for metabolic labeling and the other for immunoblot analysis. For metabolic labeling, 48 h after transfection, we incubated cells with 1 mCi of 32 P orthophosphoric acid (NEN) per ml of phosphate-free Dulbecco's modified Eagle medium supplemented with dialyzed fetal bovine serum for 4 h. We washed cells in 20 mM Na-HEPES buffer (pH 7.4) and 150 mM NaCl; lysed them in 20 mM NaPO 4 , 150 mM NaCl, 2 mM MgCl 2 , 0.1% Nonidet P-40, 10% glycerol, 3 mg ml À1 leupeptin, 3 mg ml À1 pepstatin, 1 mM phenylmethylsulfonyl fluoride, 50 mM NaVO 4 , 5 mM NaF, 100 nM okadaic acid and 5 mM b-glycerol phosphate; and immunoprecipitated equal amounts of protein with agaroseconjugated Flag M2 or Myc beads (Sigma) for 2 h. We resolved samples through a 12% SDS PAGE gel and exposed them to a phosphoimager screen.
Immunoblotting. We collected cell lysates and carried out immunoprecipitations as described 20 . We separated cell lysates or immunoprecipitated proteins through 12% SDS PAGE gels, electroblotted them and incubated them with the indicated antibody as described 20 . We visualized blots using the Super Signal Luminescent detection protocol (Pierce). Rabbit antiserum to phosphorylated Hand was commercially prepared by Sigma using the peptide shown in Figure 2 as antigen.
Two-dimensional phosphopeptide mapping. We grew HEK293 cells, transfected them, labeled them with 32 P and immunoprecipitated them exactly as described 20 . We visualized TLC and gel exposures by phosphoimager. We quantified peptide intensities using Image Quant phosphoimager software. We placed equal-sized volume boxes over variable experimental and invariant control phosphopeptides and calculated the integrated volumes and volume ratios of affected to control peptides.
FRET. We transfected HEK293 cells on glass cover slips with the indicated constructs, grew them for 48 h, fixed them and mounted them. We measured acceptor photobleaching of FRET efficiency exactly as described 25 . We examined the fluorescence emission from the donor and the acceptor in each cell to ensure that assayed cells expressed equivalent levels of CFP and YFP. The fluorescence emission from the donor and the acceptor were collected sequentially. Average fluorescence intensities of the donor were measured before and after bleaching. We collected at least 30 data points for each dimer pair. We calculated FRET efficiency using the formula E T ¼ (1 À (I DA /I D )) Â 100, where I DA and I D represent the steady-state donor fluorescence in the presence and the absence of the acceptor, respectively.
In situ hybridization. We carried out nonradioactive whole mount and section in situ hybridization as previously described 40 . We used probes for Hand2 Virology. We used SPF White Leghorn chick embryos (Charles River) for all experiments. We generated concentrated virus stocks of the indicated viruses as described, and all viruses had titers of at least 5 Â 10 8 infectious particles per ml (ref. 39 ). Flag-chick Twist1 and Flag-chick Twist1 T109A S111A protein expression and nuclear localization were confirmed by anti-Flag M2 immunostaining. For single virus experiments, embryos at stage 10-20 were either generally or focally infected in the forelimb and hindlimb fields using standard procedures 39 . For double virus experiments, (A) and (B) coat viruses were combined to equal titers, and stage 20-21 wing buds were focally infected under the anterior AER. We collected embryos through E10 for subsequent analyses. We examined E10 chick limb skeletal and soft tissue morphologies by alcian green staining followed by clearing in BABB (1:2 v/v benzyl alcohol:benzyl benzoate). We scored digit identities as described 43 . We carried out statistical comparisons using the Mann-Whitney test for nonparametric distributions.
Mice. We used outbred Swiss Webster mice (Taconic) for wild-type embryo collection. Noon of the day on which we observed a mating plug was considered E0.5. We obtained Hand2 +/À mice 41 on a mixed 129.B6 background and backcrossed them to B6 mice through N5. We maintained Twist1 tm1Bhr/+ mice 4 (Jackson Laboratory) on a B6 background. We observe 44% penetrance (n ¼ 124 Twist1 tm1Bhr/+ mice) of hindlimb polydactyly on this background. We intercrossed Hand2 +/À B6(N2) to B6(N5) and Twist1 tm1Bhr/+ mice and scored the presence of ectopic digits on hindlimbs of F 1 progeny. As the Hand2 +/À B6 backcross generation had no effect on the frequency of polydactyly in Twist1 tm1Bhr/+ Hand2 +/+ mice, we pooled data from all generations. We genotyped mice by PCR for Twist1 (ref. 9 ) and Hand2 alleles 41 as described. We carried out alizarin red staining of skeletal preparations as described 44 . Experimental protocols involving vertebrate animal use were approved by the Columbia University College of Physicians and Surgeons Institutional Animal Care and Use Committee.
Accession numbers. GenBank: mouse Twist1, M63649; mouse Twist2, U36384; mouse Hand1, S79216; mouse Hand2, U40039, mouse Tcf15 (also called Paraxis), U18658, mouse Scx (also called Scleraxis), S78079; mouse Ferd3l, AF517121; chick Twist1, AF093816; chick Twist2, AJ131110; chick Hand1, U40041; chick Hand2, U40040, chick Paraxis, U72641; human TWIST1, U80998; human TWIST2, NM_057179; rat Twist1, AF266260; Xenopus laevis Twist1, NM_204084; Drosophila melanogaster Twist, X14569; zebrafish Twist1, AF205259; zebrafish Twist2, AF205258; zebrafish Hand, AF228334; mouse Hrt1 (also called hey1), AF172286; mouse myogenin, M84918.1. GenBank Protein: C. elegans Twist, NP_509367.
